Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
European Urology|January 1, 1992
Buserelin treatment of advanced prostatic carcinoma: prognostic factor analysisA Veronesi, G Lo Re, V Dal Bo, et al.
BMC Genomics|March 12, 2015
Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytesAdrian B Hehl, Walter U Basso, Christoph Lippuner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2012
Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter studyA Brunello, U Basso, C Sacco, et al.
Leukemia|May 1, 1993
Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary resultsM C Petti, F Mandelli, V Zagonel, et al.
European Journal of Cancer Care|October 12, 2016
Performance of the Multidimensional Geriatric Assessment and Multidimensional Prognostic Index in predicting negative outcomes in older adults with cancerV Giantin, C Falci, E De Luca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2010
EORTC elderly task force position paper: approach to the older cancer patientA G Pallis, C Fortpied, U Wedding, et al.
Cancer Research|November 14, 1997
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory moleculesL Trentin, R Zambello, R Sancetta, et al.
Neurology|June 27, 2002
A multidrug combination designed for reversing resistance to BCNU in glioblastoma multiformeA A Brandes, S Turazzi, U Basso, et al.
Tumori|November 1, 1976
[The out-patient clinic for medical oncology treatment. Experience at the Istituto Nazionale Tumori of Milan (author's transl)]M De Lena, G Tancini, C Brambilla, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Pageof 20